<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-18T23:16:36Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/12963" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/12963</identifier><datestamp>2026-10-18T20:43:16Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Synthesis, Biological Evaluation and In Silico Studies of Some 2-Substituted Benzoxazole Derivatives as Potential Anticancer Agents to Breast Cancer</dc:title><dc:creator>Kuzu, Burak</dc:creator><dc:creator>Hepokur, Ceylan</dc:creator><dc:creator>Alagoz, Mehmet Abdullah</dc:creator><dc:creator>Burmaoglu, Serdar</dc:creator><dc:creator>Algul, Oztekin</dc:creator><dc:subject>anticancer activity</dc:subject><dc:subject>benzoxazole</dc:subject><dc:subject>COX inhibition</dc:subject><dc:subject>cytotoxic activity</dc:subject><dc:subject>molecular docking</dc:subject><dc:subject>CELL-CYCLE</dc:subject><dc:subject>ANTIOXIDANT STATUS</dc:subject><dc:subject>THALIDOMIDE</dc:subject><dc:subject>INFLAMMATION</dc:subject><dc:subject>INHIBITORS</dc:subject><dc:subject>DRUG</dc:subject><dc:subject>CYCLOOXYGENASE-2</dc:subject><dc:subject>PROGRESSION</dc:subject><dc:subject>CELECOXIB</dc:subject><dc:subject>Chemistry, Multidisciplinary</dc:subject><dc:subject>Chemistry</dc:subject><dc:description>In an attempt to develop potent and selective anticancer agents, some 5- or 6- and N-substituted benzoxazol-2-carboxamide derivatives were designed, synthesized, and evaluated for their cyclooxygenase inhibitory, antioxidant, and anti-proliferative activity against MCF-7 and MDA-MB-231 cell lines. Among them 5-OMe, N-piperidine substituted (compound 30), 5-OMe, N-4-methylpiperidine substituted (compound 31) and 5-Cl, N-piperidine substituted (compound 34) benzoxazole 2-carboxamide compounds have a moderate inhibitory effect in COX-1 and COX-2 enzymes. Anti-proliferative studies show that compound 30 (IC50=5.35 μM) and compound 31 (IC50=5.82 μM) have similar activity to reference drug 5-FU (IC50=3.95 μM) on MCF-7 cell but they have lower toxic effect for healthy WI-38 cell line. For the MCF-7 cell line, compounds 30 and 31 show approximately 1.5 times higher selectivity compared to the 5-FU control. Among the synthesized compounds 30, 31, and 34 had the best anti-proliferative effect and were used to perform flow cytometry and cell cycle analysis on MCF-7 cell line. To predict the binding modes and pharmacokinetic parameters of all compounds, in silico studies were carried out. These compounds may shed light on cancer treatment and cancer research. © 2022 Wiley-VCH GmbH</dc:description><dc:publisher>John Wiley and Sons Inc</dc:publisher><dc:date>2022</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/12963</dc:identifier><dc:identifier>https://doi.org/10.1002/slct.202103559</dc:identifier><dc:identifier>2365-6549</dc:identifier><dc:language>en</dc:language><dc:relation>ChemistrySelect</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/12963</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>